Register entry

Nova Biologicals, Inc.

Data as of · How to read this entry

Registered sites
2
Active NDC listings
3
Labeller names
2
Live patents
1
Exclusivities
1
Countries
2
Base
United States
Authorisation

Registered operations

Analytical testing1Finished drug manufacture1
Sites

Registered establishments

2
EstablishmentAddressRegistered forFEI / DUNS
Nova Laboratories LtdGloucester Cresent, Wigston, Leicestershire LE18 4YL, United Kingdom (GBR)Finished drug manufacture3000323524230804692
Nova Biologicals, Inc.1775 N Loop 336 E, Ste 4, Conroe, Texas (TX) 77301, United States (USA)Analytical testing1641521802721324
Catalogue

Drug listings by form and route

3

3 active NDC listings: 3 human prescription drug. By marketing category: NDA 2, NDA AUTHORIZED GENERIC 1.

Dosage formNDCs
suspension2
solution1
RouteNDCs
oral3
Labeller name on the listingNDCs
nova laboratories, ltd2
nova laboratories, ltd.1
Exclusivity

Patents and exclusivities

1
PatentProductCoversExpiry
12409156XROMIhydroxyureaproductDec 2041
ProductExclusivityUntil
XROMIHYDROXYUREAODE-470 Orphan drugApr 2031
Catalogue

Marketed products

3
BrandGeneric nameForm / routeNDC
MERCAPTOPURINEMERCAPTOPURINEsuspension, oral62484-1020NDA AUTHORIZED GENERIC
PURIXANPurixansuspension, oral62484-0020NDA
XROMIHydroxyureasolution, oral62484-0015NDA
Neighbours

Registered in the same town

1
Compare

Comparable companies in United States

Enquiry

Common questions

Is Nova Biologicals, Inc. FDA approved?
Nova Biologicals, Inc. holds 2 FDA-registered establishments across 2 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Nova Biologicals, Inc.'s drugs manufactured?
At registered sites in the United Kingdom, the United States. The FDA register lists Wigston; Conroe, TX. Registered operations: analytical testing, finished drug manufacture.
What drugs does Nova Biologicals, Inc. make?
3 products are listed under Nova Biologicals, Inc. in the openFDA NDC Directory, most often as suspension; solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.